Sovenyr
Subscribe
Signal
2026-07-01
EPO Patents
[EPO] METHODS AND COMPOSITIONS FOR ASSESSING IMMUNE RESPONSE TO LIPID COMPOSITIONS
Part of
Early Phase Immune Therapeutics Trials
Open primary source
Read on Substack